LRRC70
gene geneOn this page
Also known as SLRNLOC100130733
Summary
LRRC70 (leucine rich repeat containing 70, HGNC:35155) is a protein-coding gene on chromosome 5q12.1, encoding Leucine-rich repeat-containing protein 70 (Q7Z2Q7). Renders cells highly sensitive to the activation by cytokines and lipopolysaccharide (LPS).
Involved in positive regulation of response to cytokine stimulus. Located in plasma membrane.
Source: NCBI Gene 100130733 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_181506
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:35155 |
| Approved symbol | LRRC70 |
| Name | leucine rich repeat containing 70 |
| Location | 5q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SLRN, LOC100130733 |
| Ensembl gene | ENSG00000186105 |
| Ensembl biotype | protein_coding |
| Entrez | 100130733 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000334994, ENST00000448151, ENST00000491184
RefSeq mRNA: 1 — MANE Select: NM_181506
NM_181506
CCDS: CCDS47218
Canonical transcript exons
ENST00000334994 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001337991 | 62579401 | 62581446 |
| ENSE00001674472 | 62578819 | 62578935 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 83.26.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0250 / max 4.8754, expressed in 8 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 56648 | 2.7318 | 376 |
| 56649 | 0.0250 | 8 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.26 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 80.20 | gold quality |
| adipose tissue | UBERON:0001013 | 80.08 | gold quality |
| omental fat pad | UBERON:0010414 | 79.94 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 78.53 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 78.27 | gold quality |
| spleen | UBERON:0002106 | 77.57 | gold quality |
| gall bladder | UBERON:0002110 | 77.23 | gold quality |
| left uterine tube | UBERON:0001303 | 75.80 | gold quality |
| thyroid gland | UBERON:0002046 | 75.36 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 74.83 | gold quality |
| calcaneal tendon | UBERON:0003701 | 74.71 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 74.40 | gold quality |
| placenta | UBERON:0001987 | 74.39 | gold quality |
| myometrium | UBERON:0001296 | 73.19 | gold quality |
| tibial nerve | UBERON:0001323 | 73.18 | gold quality |
| ectocervix | UBERON:0012249 | 73.13 | gold quality |
| endocervix | UBERON:0000458 | 73.08 | gold quality |
| body of uterus | UBERON:0009853 | 72.94 | gold quality |
| blood | UBERON:0000178 | 72.16 | gold quality |
| skin of abdomen | UBERON:0001416 | 71.78 | gold quality |
| mucosa of stomach | UBERON:0001199 | 71.65 | gold quality |
| left coronary artery | UBERON:0001626 | 71.41 | gold quality |
| vagina | UBERON:0000996 | 71.35 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 71.28 | gold quality |
| uterine cervix | UBERON:0000002 | 71.21 | gold quality |
| zone of skin | UBERON:0000014 | 71.21 | gold quality |
| fallopian tube | UBERON:0003889 | 71.20 | gold quality |
| skin of leg | UBERON:0001511 | 71.10 | gold quality |
| tibial artery | UBERON:0007610 | 71.05 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | yes | 453.37 |
| E-ANND-3 | yes | 2.98 |
| E-MTAB-6678 | no | 3.05 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Synleurin, a novel leucine-rich repeat protein that increases the intensity of pleiotropic cytokine and growth factor responses. (PMID:12767927)
Cross-species orthologs
0 orthologs
Paralogs (25): SLITRK3 (ENSG00000121871), LRFN3 (ENSG00000126243), LRFN1 (ENSG00000128011), SLIT2 (ENSG00000145147), LRFN2 (ENSG00000156564), LRRC38 (ENSG00000162494), SLITRK5 (ENSG00000165300), LRFN5 (ENSG00000165379), LRTM2 (ENSG00000166159), LINGO1 (ENSG00000169783), LRRN2 (ENSG00000170382), LRRN3 (ENSG00000173114), LRFN4 (ENSG00000173621), LINGO2 (ENSG00000174482), LRRN1 (ENSG00000175928), SLITRK1 (ENSG00000178235), GP5 (ENSG00000178732), SLITRK4 (ENSG00000179542), LRRC55 (ENSG00000183908), SLIT3 (ENSG00000184347), SLITRK6 (ENSG00000184564), SLITRK2 (ENSG00000185985), SLIT1 (ENSG00000187122), TLR9 (ENSG00000239732), TPBGL (ENSG00000261594)
Protein
Protein identifiers
Leucine-rich repeat-containing protein 70 — Q7Z2Q7 (reviewed: Q7Z2Q7)
Alternative names: Synleurin
All UniProt accessions (2): Q7Z2Q7, D6RD14
UniProt curated annotations — full annotation on UniProt →
Function. Renders cells highly sensitive to the activation by cytokines and lipopolysaccharide (LPS).
Subcellular location. Membrane.
Tissue specificity. Expressed at low levels in many tissues, including smooth muscle, brain, uterus, pancreas, cartilage, adipose, spleen and testis.
RefSeq proteins (1): NP_852607* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000483 | Cys-rich_flank_reg_C | Domain |
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR026906 | LRR_5 | Repeat |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR050328 | Dev_Immune_Receptor | Family |
Pfam: PF13306, PF13855
UniProt features (22 total): repeat 12, glycosylation site 4, domain 2, signal peptide 1, chain 1, transmembrane region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z2Q7-F1 | 73.99 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (4): 215, 266, 331, 400
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 20 (showing top):
GOBP_RESPONSE_TO_PEPTIDE, GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS, chr5q12, GOBP_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS, MIR548L, MIR6891_5P, MIR12118, MIR3173_3P, DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS, DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS, DESCARTES_FETAL_LUNG_LYMPHATIC_ENDOTHELIAL_CELLS, NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE, HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_UP, HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN, TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL
GO Biological Process (1): positive regulation of response to cytokine stimulus (GO:0060760)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| response to cytokine | 1 |
| positive regulation of response to stimulus | 1 |
| regulation of response to cytokine stimulus | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
398 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRC70 | IPO11 | Q9UI26 | 847 |
| LRRC70 | RPL12 | P30050 | 762 |
| LRRC70 | IPO5 | O00410 | 712 |
| LRRC70 | RPL23A | P29316 | 712 |
| LRRC70 | UBE2E3 | Q969T4 | 501 |
| LRRC70 | OR1B1 | Q8NGR6 | 474 |
| LRRC70 | PDGFB | P01127 | 453 |
| LRRC70 | CNPPD1 | Q9BV87 | 434 |
| LRRC70 | FGF13 | Q92913 | 402 |
| LRRC70 | INAVA | Q3KP66 | 398 |
| LRRC70 | WFDC12 | Q8WWY7 | 370 |
| LRRC70 | IGF2 | P01344 | 365 |
| LRRC70 | FGF2 | P09038 | 358 |
| LRRC70 | WFDC5 | Q8TCV5 | 348 |
| LRRC70 | ZNF415 | Q09FC8 | 348 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LRRC70 | H2BC9 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (3): LRRC70 (Affinity Capture-MS), HIST1H2BH (Proximity Label-MS), LRRC70 (Proximity Label-MS)
ESM2 similar proteins: A4D1F6, A4IIK1, A6H6A4, A6NIV6, A6NM36, C0STK7, D3ZXS4, F1R6I3, F6R2G2, P14605, Q09562, Q32KX5, Q38SD2, Q3TX51, Q3UHC2, Q3UV48, Q3ZC49, Q4R6F0, Q54AX5, Q58A48, Q5G5E0, Q62192, Q65YW8, Q65Z91, Q66HD6, Q6AXL3, Q6GLE8, Q6GM71, Q6R5N8, Q6ZNQ3, Q7Z2Q7, Q86X40, Q8BGI7, Q8C0R9, Q8N456, Q8VDB8, Q96DD0, Q99467, Q99MB1, Q9BYS8
Diamond homologs: A8WGA3, B1H134, B1H234, D3ZTV3, D4ABX8, F1NUK7, G5EFX6, O42235, O43155, O55226, O60938, O75093, O88279, O88280, O94769, O94991, P04629, P13224, P14770, P24014, P50608, P50609, P56400, P59383, P83503, Q04785, Q06828, Q3UHC2, Q5R6T0, Q5RAC4, Q5RI43, Q6RKD8, Q6WRH9, Q70AK3, Q7Z2Q7, Q80TR4, Q80XU8, Q810B7, Q810C1, Q8BGT1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
192 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:62578903:C:G | donor_gain | 0.9900 |
| 5:62579399:A:AG | acceptor_gain | 0.9800 |
| 5:62579400:G:GG | acceptor_gain | 0.9800 |
| 5:62579400:GCCA:G | acceptor_gain | 0.9800 |
| 5:62579617:A:T | donor_gain | 0.9800 |
| 5:62579485:T:TA | donor_gain | 0.9600 |
| 5:62578853:T:G | donor_gain | 0.9500 |
| 5:62579622:AC:A | donor_gain | 0.9500 |
| 5:62579398:T:G | acceptor_gain | 0.9400 |
| 5:62579400:GC:G | acceptor_gain | 0.9300 |
| 5:62579400:GCC:G | acceptor_gain | 0.9000 |
| 5:62579486:T:TA | donor_gain | 0.9000 |
| 5:62578931:TCTTG:T | donor_loss | 0.8900 |
| 5:62578932:CTTGG:C | donor_loss | 0.8900 |
| 5:62578933:TTG:T | donor_loss | 0.8900 |
| 5:62578934:TGGT:T | donor_loss | 0.8900 |
| 5:62578935:GGTAA:G | donor_loss | 0.8900 |
| 5:62578936:GT:G | donor_loss | 0.8900 |
| 5:62578937:TAAGA:T | donor_loss | 0.8900 |
| 5:62578938:A:C | donor_loss | 0.8700 |
| 5:62578936:G:GG | donor_gain | 0.8500 |
| 5:62579488:T:G | donor_gain | 0.8400 |
| 5:62579619:A:AG | donor_gain | 0.8400 |
| 5:62579620:G:GG | donor_gain | 0.8400 |
| 5:62578850:GAGT:G | donor_gain | 0.8200 |
| 5:62579397:ATAGC:A | acceptor_loss | 0.7900 |
| 5:62579398:TA:T | acceptor_loss | 0.7900 |
| 5:62579399:A:AC | acceptor_loss | 0.7900 |
| 5:62579400:G:A | acceptor_loss | 0.7900 |
| 5:62579400:GCCAA:G | acceptor_gain | 0.7900 |
AlphaMissense
4058 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:62580519:T:A | W361R | 0.991 |
| 5:62580519:T:C | W361R | 0.991 |
| 5:62580521:G:C | W361C | 0.987 |
| 5:62580521:G:T | W361C | 0.987 |
| 5:62580427:T:C | L330P | 0.980 |
| 5:62580433:T:C | L332P | 0.975 |
| 5:62580427:T:A | L330H | 0.971 |
| 5:62580352:T:C | L305P | 0.970 |
| 5:62580136:T:C | L233P | 0.969 |
| 5:62580064:T:C | L209S | 0.967 |
| 5:62580443:T:A | N335K | 0.967 |
| 5:62580443:T:G | N335K | 0.967 |
| 5:62579920:T:C | L161S | 0.966 |
| 5:62579926:T:C | L163P | 0.965 |
| 5:62579992:T:A | L185H | 0.965 |
| 5:62580208:T:C | L257P | 0.964 |
| 5:62580433:T:A | L332Q | 0.964 |
| 5:62580499:T:C | L354P | 0.964 |
| 5:62580515:T:A | N359K | 0.964 |
| 5:62580515:T:G | N359K | 0.964 |
| 5:62580525:T:A | C363S | 0.964 |
| 5:62580525:T:C | C363R | 0.964 |
| 5:62580526:G:C | C363S | 0.964 |
| 5:62579792:T:A | N118K | 0.963 |
| 5:62579792:T:G | N118K | 0.963 |
| 5:62580085:T:C | L216S | 0.963 |
| 5:62580136:T:A | L233H | 0.962 |
| 5:62580433:T:G | L332R | 0.961 |
| 5:62579998:T:C | L187S | 0.960 |
| 5:62581053:T:C | C539R | 0.960 |
dbSNP variants (sampled 300 via entrez): RS1000732389 (5:62581740 GA>G,GAA), RS1001633149 (5:62578815 T>G), RS1002072423 (5:62578813 G>A), RS1002132219 (5:62580627 C>T), RS1003388292 (5:62579234 C>A), RS1004602264 (5:62580255 A>C,G,T), RS1005105011 (5:62577300 C>T), RS1005659200 (5:62580508 A>G), RS1006316409 (5:62578316 T>A), RS10066921 (5:62578802 A>C), RS1007159621 (5:62580300 T>A,G), RS1007497172 (5:62579951 T>C), RS1007910425 (5:62581911 C>T), RS1008116532 (5:62578919 C>T), RS1009430946 (5:62579618 A>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007324_14 | Adventurousness | 1.000000e-10 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008579 | risk-taking behaviour |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | affects expression | 1 |
| 2-butenal | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| abrine | increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.